MARLEEN YOSEF: Open Payments
NPI 1972110831 · ANTIOCH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,920 in 63 payments from 14 companies in 2025. Trend: 2023 $1,693 · 2024 $1,260 · 2025 $1,920
Food & beverage: $1,920
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $417 |
| ABBVIE INC. | 7 | $328 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $319 |
| GENZYME CORPORATION | 5 | $181 |
| UCB, Inc. | 6 | $174 |
| Galderma Laboratories, L.P. | 4 | $165 |
| Regeneron Healthcare Solutions, Inc. | 2 | $125 |
| Lilly USA, LLC | 2 | $43 |
| PFIZER INC. | 1 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
Products named: TREMFYA, SKYRIZI, Bimzelx, NEMLUVIO, DUPIXENT, Leqselvi, ILUMYA, Winlevi.
Industry payments across TN — which companies pay providers there.
